Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06729840

Intralesional Treatment of Keloids

Intralesional injection in treatment of keloid

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Scar, Hypertrophic Cicatrix Cicatrix, Hypertrophic Collagen Diseases Connective Tissue Diseases Fibrosis Keloid Pathologic Processes Pathological Conditions, Signs and Symptoms Skin and Connective Tissue Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

About this study

Our study will include 45 patient diveded into three groups , follow up will done before each session , 3month after the last session using photographing assessment , scoring , dermoscope

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Both sex aged 18-60 having keloid

-

Exclusion criteria

  • pregnancy , lactation Skin disease

Treatment and study plan

Injection

Drug

Vitamin D , botox , tramcinolone intralesionally injected in keloid

Primary outcomes

  1. Posas score

    Time frame: One session every two weeks total duration 3 months

    patient and observer parameters will be assessed

Study contacts

Contact information is provided by the study sponsor or research team.

sama alaa, resident doctor

CONTACT

[email protected]

01027748791

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Vitamin D in Keloids

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 11, 2024
Registry last updated
Dec 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.